|
|
||||||||


*
Department of Biological Sciences, Rutgers University, Newark, NJ 07102; and
Departamento Biologia Celular, Universidad Complutense, Madrid, Spain
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase
activating polypeptide (PACAP), two structurally related neuropeptides
produced and/or released within the lymphoid microenvironment, modulate
numerous immune functions. Although primarily antiinflammatory in
nature, VIP and PACAP also affect resting macrophages. In this study,
we report on in vitro and in vivo dual effects of VIP/PACAP on the
expression of B7.1 and B7.2 and on the costimulatory activity for T
cells in unstimulated and LPS/IFN-
-activated macrophages. VIP and
PACAP up-regulate B7.2, but not B7.1, expression and induce the
capacity to stimulate the proliferation of naive T cells in response to
soluble anti-CD3 or allogeneic stimulation. In contrast, both
neuropeptides down-regulate B7.1/B7.2 expression on
LPS/IFN-
-activated macrophages and inhibit the endotoxin-induced
costimulatory activity for T cells. Interestingly, both the stimulatory
and the inhibitory effects of VIP/PACAP are mediated through the
specific receptor VPAC1 and involve the cAMP/protein kinase A
transduction pathway. The dual effect on B7.1 and B7.2 expression
occurs at both mRNA and protein level and correlates with the VIP/PACAP
regulation of the macrophage costimulatory activity. Through their
regulatory role for resting and activated macrophages, VIP and PACAP
act as endogenous participants in the control of immune homeostasis.
Their effects depend not only on the timing of their release, but also
on the activation and differentiation state of the neighboring immune
cells.
This article has been cited by other articles:
![]() |
Y.-A. Zhang, J.-i. Hikima, J. Li, S. E. LaPatra, Y.-P. Luo, and J. O. Sunyer Conservation of Structural and Functional Features in a Primordial CD80/86 Molecule from Rainbow Trout (Oncorhynchus mykiss), a Primitive Teleost Fish J. Immunol., July 1, 2009; 183(1): 83 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Michalski, F. Selvaggi, M. Bartel, T. Mitkus, A. Gorbachevski, T. Giese, P. D. Sebastiano, N. A. Giese, and H. Friess Altered anti-inflammatory response of mononuclear cells to neuropeptide PACAP is associated with deregulation of NF-{kappa}B in chronic pancreatitis Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G50 - G57. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fabricius, M. S. O'Dorisio, S. Blackwell, and B. Jahrsdorfer Human Plasmacytoid Dendritic Cell Function: Inhibition of IFN-{alpha} Secretion and Modulation of Immune Phenotype by Vasoactive Intestinal Peptide J. Immunol., November 1, 2006; 177(9): 5920 - 5927. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kato, A. Ito, J. Kawanokuchi, S. Jin, T. Mizuno, K. Ojika, R. Ueda, and A. Suzumura Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells Multiple Sclerosis, December 1, 2004; 10(6): 651 - 659. [Abstract] [PDF] |
||||
![]() |
S. Kodali, W. Ding, J. Huang, K. Seiffert, J. A. Wagner, and R. D. Granstein Vasoactive Intestinal Peptide Modulates Langerhans Cell Immune Function J. Immunol., November 15, 2004; 173(10): 6082 - 6088. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Delgado, D. Pozo, and D. Ganea The Significance of Vasoactive Intestinal Peptide in Immunomodulation Pharmacol. Rev., June 1, 2004; 56(2): 249 - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Delgado, A. Reduta, V. Sharma, and D. Ganea VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4+ T cells J. Leukoc. Biol., June 1, 2004; 75(6): 1122 - 1130. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Grimm, R. Newman, Z. Hassim, N. Cuan, S. J. Connor, Y. Le, J. M. Wang, J. J. Oppenheim, and A. R. Lloyd Cutting Edge: Vasoactive Intestinal Peptide Acts as a Potent Suppressor of Inflammation In Vivo by Trans-Deactivating Chemokine Receptors J. Immunol., November 15, 2003; 171(10): 4990 - 4994. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Brinker, H. Garner, and J. R. Wright Surfactant protein A modulates the differentiation of murine bone marrow-derived dendritic cells Am J Physiol Lung Cell Mol Physiol, January 1, 2003; 284(1): L232 - L241. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ganea and M. Delgado VASOACTIVE INTESTINAL PEPTIDE (VIP) AND PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AS MODULATORS OF BOTH INNATE AND ADAPTIVE IMMUNITY Critical Reviews in Oral Biology & Medicine, May 1, 2002; 13(3): 229 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kuroda, T. Sugiura, K. Okada, K. Zeki, and U. Yamashita Prostaglandin E2 Up-Regulates Macrophage-Derived Chemokine Production but Suppresses IFN-Inducible Protein-10 Production by APC J. Immunol., February 1, 2001; 166(3): 1650 - 1658. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Delgado and D. Ganea Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Inhibit Expression of Fas Ligand in Activated T Lymphocytes by Regulating c-Myc, NF-{{kappa}}B, NF-AT, and Early Growth Factors 2/3 J. Immunol., January 15, 2001; 166(2): 1028 - 1040. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Elenkov, R. L. Wilder, G. P. Chrousos, and E. S. Vizi The Sympathetic Nerve---An Integrative Interface between Two Supersystems: The Brain and the Immune System Pharmacol. Rev., December 1, 2000; 52(4): 595 - 638. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Vaudry, B. J. Gonzalez, M. Basille, L. Yon, A. Fournier, and H. Vaudry Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: From Structure to Functions Pharmacol. Rev., June 1, 2000; 52(2): 269 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Delgado and D. Ganea Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Inhibit Antigen-Induced Apoptosis of Mature T Lymphocytes by Inhibiting Fas Ligand Expression J. Immunol., February 1, 2000; 164(3): 1200 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Delgado and D. Ganea Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Polypeptide Inhibit Nuclear Factor-kappa B-dependent Gene Activation at Multiple Levels in the Human Monocytic Cell Line THP-1 J. Biol. Chem., January 5, 2001; 276(1): 369 - 380. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |